309 related articles for article (PubMed ID: 29234323)
1. Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.
Zanoni I; Granucci F; Broggi A
Front Immunol; 2017; 8():1661. PubMed ID: 29234323
[TBL] [Abstract][Full Text] [Related]
2. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
4. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
Stanifer ML; Guo C; Doldan P; Boulant S
Front Immunol; 2020; 11():608645. PubMed ID: 33362795
[TBL] [Abstract][Full Text] [Related]
5. Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.
Kelly A; Robinson MW; Roche G; Biron CA; O'Farrelly C; Ryan EJ
J Interferon Cytokine Res; 2016 Dec; 36(12):671-680. PubMed ID: 27617757
[TBL] [Abstract][Full Text] [Related]
6. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
[TBL] [Abstract][Full Text] [Related]
7. Expression of
Baldridge MT; Lee S; Brown JJ; McAllister N; Urbanek K; Dermody TS; Nice TJ; Virgin HW
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077655
[TBL] [Abstract][Full Text] [Related]
8. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
9. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
Yin Y; Romero N; Favoreel HW
J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
[TBL] [Abstract][Full Text] [Related]
10. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
Pervolaraki K; Stanifer ML; Münchau S; Renn LA; Albrecht D; Kurzhals S; Senís E; Grimm D; Schröder-Braunstein J; Rabin RL; Boulant S
Front Immunol; 2017; 8():459. PubMed ID: 28484457
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Type III Interferon (IFN) Genes
Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
[TBL] [Abstract][Full Text] [Related]
12. Differential Regulation of Type I and Type III Interferon Signaling.
Stanifer ML; Pervolaraki K; Boulant S
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901970
[TBL] [Abstract][Full Text] [Related]
13. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.
Philip DT; Goins NM; Catanzaro NJ; Misumi I; Whitmire JK; Atkins HM; Lazear HM
mBio; 2024 Apr; 15(4):e0262323. PubMed ID: 38426749
[TBL] [Abstract][Full Text] [Related]
14. Herpesviruses and the Type III Interferon System.
Yin Y; Favoreel HW
Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
16. [Action of type III IFNs and their roles in immune responses].
Domagalski K; Tretyn A; Pawłowska M; Szczepanek J; Halota W
Postepy Hig Med Dosw (Online); 2010 Oct; 64():522-33. PubMed ID: 21109705
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 27, like interferons, activates JAK-STAT signaling and promotes pro-inflammatory and antiviral states that interfere with dengue and chikungunya viruses replication in human macrophages.
Valdés-López JF; Hernández-Sarmiento LJ; Tamayo-Molina YS; Velilla-Hernández PA; Rodenhuis-Zybert IA; Urcuqui-Inchima S
Front Immunol; 2024; 15():1385473. PubMed ID: 38720890
[TBL] [Abstract][Full Text] [Related]
18. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
[TBL] [Abstract][Full Text] [Related]
19. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
Sojati J; Parks OB; Zhang Y; Walters S; Lan J; Eddens T; Lou D; Fan L; Chen K; Oury TD; Williams JV
mBio; 2024 May; 15(5):e0055024. PubMed ID: 38530032
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation.
Mesev EV; Guare EG; Ploss A; Toettcher JE
J Interferon Cytokine Res; 2023 Sep; 43(9):414-426. PubMed ID: 37725008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
